Navigation Links
Eclipsys Announces Strong Market Momentum for Sunrise Pharmacy
Date:12/3/2007

venue cycle and access management software, clinical content and professional services that help healthcare organizations improve clinical, financial, operational and client satisfaction outcomes. For more information, see http://www.eclipsys.com or email info@eclipsys.com.

Statements in this news release concerning the benefits provided by Eclipsys software are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Implementation and customization of Eclipsys software is complex and time- consuming. Results depend upon a variety of factors and can vary by client. Each client's circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from software. The success and timeliness of the company's software and services will depend at least in part upon client involvement, which can be difficult to control. Eclipsys is required to meet specified performance standards, and the contract can be terminated or its scope reduced under certain circumstances. More information about company risks is available in recent Form 10-Q and 10-K filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations." Eclipsys Corporation and The Outcomes Company are registered trademarks of Eclipsys Corporation. Sunrise Clinical Manager, Knowledge-Based CPOE, and Sunrise Pharmacy are trademarks of Eclipsys Corporation. Other product and company names in this news release are trademarks and/or registered trademarks of their respective companies.

Eclipsys

Jason Cigarran Robert J. Colletti

Director of Media Rel
'/>"/>

SOURCE Eclipsys Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes
2. Eclipsys User Network Brings Eclipsys Clients Together to Share Outcome Improvement Strategies
3. SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America
4. Eclipsys Announces Relocation of Corporate Headquarters to Atlanta, GA
5. Eclipsys Sunrise Acute Care Receives CCHIT Certification
6. Eclipsys to Present at Piper Jaffray Healthcare Conference
7. Eclipsys to Present at the Merrill Lynch Health Services Investor Conference
8. Eclipsys Sunrise Radiology Helps Trinitas Hospital Achieve Financial Outcome Improvements
9. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
10. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
11. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...heory that bringing about senescence in aged cells...ucing senescence in aged cells may be sufficient t...cording to a paper published online this week in E...EMBO reports). It was previously unknown whether c...
...aul flights on air crew is hazardous, scientists h...t jet lag// complain of menstrual irregularities, ...nd in the way of good health. The body’s routine ...vel across different time zones. The body’s cycles...
... Northern Ireland has sought for the cancer drugs ...t such prescriptions will be free from April 1// a...follow suit. In Northern Ireland around 9,000 peo...r. Heather Monteverde from the charity said that i...
... have identified the receptor pathway used by estr...orrhage//. The related report by Hsieh et al, “G p...e A pathway is critical in nongenomic effects of e...hemorrhage,” appears in the April issue of The Ame...
Other Medicine News:Health News:Estrogen Protects Liver After Traumatic Injury 2
(Date:9/4/2008)... ZURICH, Switzerland, September 4 /PRNewswire/...se IIa trial to assess the safety and tolerability...t of severe pulmonary,infection in cystic fibrosis...ed therapeutic agent to be delivered directly to t...lso compare the effects of two,different doses of ...
(Date:9/4/2008)... - 100 mg cohort demonstrates potent antiviral act... profile -, CAMBRIDGE, Mass., Sept. 4 /PRNe...(Nasdaq: IDIX ), a biopharmaceutical company enga...the treatment of human viral,and other infectious ...e,proof-of-concept study evaluating IDX899, a non-...
(Date:9/4/2008)... Data Announcements Remain on Schedule with Two...e Clinical Data Release in November 2008, BRIDGEW...aceuticals,Inc., a specialty pharmaceutical compa...metabolic disease, today announced the appointment...d of directors., Peter Garrambone,s career includ...
(Date:9/3/2008)... , NAA says: Wrong Question Asked. Wrong Children...Sept. 3 /PRNewswire-USNewswire/ -- A Centers for D... today claims there is no link,between the MMR vac...NAA),says this study does nothing to dispel the gr...ion and raises several questions concerning design...
Breaking Medicine Technology:Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2CDC Misses Target With Flawed MMR/Autism Study 2Taking more than 1 anti inflammatory drug may lead to complications 10750 1Taking more than 1 anti inflammatory drug may lead to complications 10750 2Larynx preservation preferred over total laryngectomy 10747 1Larynx preservation preferred over total laryngectomy 10747 2Wisconsin Physicians Service Insurance Corporation Aurora Health Care and HealthEOS Announce Settlement Agreement 10744 1Wisconsin Physicians Service Insurance Corporation Aurora Health Care and HealthEOS Announce Settlement Agreement 10744 2Maryland Science Center Unveils Anatomical Exhibition Body Worlds 2 on Saturday February 2 2936 1Maryland Science Center Unveils Anatomical Exhibition Body Worlds 2 on Saturday February 2 2936 2
Excellent for manipulation of the intraocular lens in the capsular bag. The angled and curved shaft allows the instrument to reach across the implant and catch the optic/ haptic junction to facilitat
Angled shaft with 1.5 mm tip designed to efficiently perform the "Stop and Chop" technique. Round knurled handle. Most popular size or model.
This double ended instrument was designed for delineating and lifting the corneal flap of previously performed lamellar refractive surgery cases.
Used when dislocating the lens. Great for chopping during phacoemulsification. Helpful in ushering the IOL out of eye. Useful to reduce possibility of iris tuck with anterior chamber IOL placement.
Medicine Products: